Search Results

Professor Roger M. Greenhalgh, MD, 1941–2023

The Charing Cross (CX) International Symposium announced the passing of its founder, Professor Roger Greenhalgh, MD, Emeritus Professor of Surgery at Imperial College in London, and head of the Vascular Surgery Research Group.

UK EVAR Trials Published and Presented at Charing Cross Symposium

April 11, 2010 — Principal investigator Professor Roger Greenhalgh, MD, and trial manager Louise C. Brown, PhD, presented the 10-year follow-up results from the United Kingdom's EVAR 1 and EVAR 2 trials of endovascular aneurysm repair (EVAR) versus open repair of abdominal aortic aneurysm (AAA) at the Charing Cross International Symposium in London. The findings were also published online ahead of print in the New England Journal of Medicine. EVAR 1 studied patients deemed fit for open surgical repair, and EVAR 2 studied patients deemed unfit for open surgical repair.

Fifteen-Year Follow-Up Data From UK EVAR 1 Trial Published

October 20, 2016—Fifteen-year follow-up data from the landmark randomized controlled United Kingdom endovascular aneurysm repair trial 1 (EVAR 1) were published by Rajesh Patel, MD, et al online ahead of print in The Lancet. EVAR 1 was led by Chief Investigator Prof.

UK EVAR Trials Published and Presented at Charing Cross

April 11, 2010—The 10-year follow-up results from the United Kingdom's EVAR 1 and EVAR 2 trials of endovascular aneurysm repair (EVAR) versus open repair of abdominal aortic aneurysm (AAA) were published online ahead of print in the New England Journal of Medicine.

Endologix Honors Innovators of Aortic Therapy at VEITHsymposium

November 15, 2018—Endologix announced that four innovators of aortic therapy were honored at the 45th annual VEITHsymposium held November 13–17 in New York, New York during the company's event, “Learning from the Past to Shape the Future: Evolution of Aortic Therapy.” Endologix recognized the surgeons who advanced aortic repair therapy and initiated early randomized controlled trials of endovascular aneurysm repair (EVAR).

Charing Cross Symposium Announces “CX 2020 Live” Virtual Event

May 13, 2020—The Charing Cross (CX) Symposium has announced the launch of an interactive vascular and endovascular education virtual event, CX 2020 Live, which is designed to deliver high-quality vascular education.

ENGAGE Global Registry and EVAR 1 Trial Data Presented for Medtronic's Endurant AAA Stent Graft

April 27, 2016—Medtronic plc announced the presentation of the ENGAGE global registry's postmarket experiences with the Endurant abdominal aortic aneurysm (AAA) stent graft system in endovascular aortic repair (EVAR); with a reference to the landmark EVAR 1 trial.

Gore Announces Nominees for 2013–2014 Pioneers in Performance Awards for Europe

April 5, 2013—At the Charing Cross International Symposium (CX) in London, England, Gore & Associates, Inc. (Flagstaff, AZ) announced the nominees for the 2013–2014 Pioneers in Performance Awards for Europe.

Gore Honors 2014 Pioneers in Performance for Europe

April 24, 2014—Gore & Associates (Flagstaff, AZ) announced the honorees of the 2014 Pioneers in Performance awards for Europe.